ReviewInternational journal of molecular sciences2019

Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy.

Yuko Iwata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.